![](/img/cover-not-exists.png)
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial
Maurie Markman, James Moon, Sharon Wilczynski, Ana Maria Lopez, Kendrith M. Rowland Jr., David P. Michelin, Victor J. Lanzotti, Garnet L. Anderson, David S. AlbertsVolume:
116
Year:
2010
Language:
english
Pages:
3
DOI:
10.1016/j.ygyno.2009.11.026
File:
PDF, 218 KB
english, 2010